Preparation of magnetic mesoporous silica nanoparticles as a multifunctional platform for potential drug delivery and hyperthermia

References

• Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer CA Cancer. J Clin. 2011;61:183–203.10.3322/caac.v61:3
   Google Scholar
• Cho K, Wang X, Nie S. Therapeutic nanoparticles for drug delivery in Cancer Clin. Cancer Res. 2008;14:1310–1316.
   Web of Science ®Google Scholar
• He Q, Shi JL. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem. 2011;21:5845–5855. 10.1039/c0jm03851b
   Web of Science ®Google Scholar
• Wang BX, Li CH, Peng XF. Research on stability of nano-particle suspension. J. Univ. Shanghai Sci. Technol. 2003;3:209–212.
   Google Scholar
• Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24:1504–1534.
   PubMed Web of Science ®Google Scholar
• Niu DC, Ma Z, Li YS, et al. Synthesis of core−shell structured dual-mesoporous silica spheres with tunable pore size and controllable shell thickness. J Am Chem Soc. 2010;132:15144–15147. 10.1021/ja1070653
   PubMed Web of Science ®Google Scholar
• Li L, Tang F, Liu H, et al. In Vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano. 2010;4:6874–6882. 10.1021/nn100918a
   PubMed Web of Science ®Google Scholar
• Jia HZ, Zhang W, Zhu JY, et al. Hyperbranched–hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy. J. Controlled Release. 2015;216:9–17. 10.1016/j.jconrel.2015.08.006
   PubMed Web of Science ®Google Scholar
• Tagliamonte M, Petrizzo A, Napolitano M, et al. Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model. Cancer Immunol Immunother. 2015;64:1305–1314. 10.1007/s00262-015-1698-0
   PubMed Web of Science ®Google Scholar
• Kumar CSSR, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Del. Rev. 2011;63:789–808. 10.1016/j.addr.2011.03.008
   PubMed Web of Science ®Google Scholar
• Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia. 2001;17:1–18. 10.1080/02656730150201552
   PubMed Web of Science ®Google Scholar
• Kobayashi T. Cancer hyperthermia using magnetic nanoparticles. Biothechnol J. 2011;6:1342–1347.
   Google Scholar
• Lee H, Kim S, Choi BH, et al. Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells. Int J Hyperthermia. 2011;27:698–707. 10.3109/02656736.2011.608217
   PubMed Web of Science ®Google Scholar
• Ito A, Shinkai M, Honda H, et al. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng. 2005;100:1–11. 10.1263/jbb.100.1
   PubMed Web of Science ®Google Scholar
• Taratula O, Dani RK, Schumann C, et al. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. Int J Pharm. 2013;458:169–180.
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhang H, Chen B, et al. Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. Int J Nanomed. 2012;7:2261–2269.
   PubMed Web of Science ®Google Scholar
• Pradhan P, Giri J, Rieken F, et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Controlled Release. 2010;142:108–121. 10.1016/j.jconrel.2009.10.002
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26:3995–4021.
   PubMed Web of Science ®Google Scholar
• Gai S, Yang P, Ma PA, et al. Fibrous-structured magnetic and mesoporous Fe3O4/silica microspheres: synthesis and intracellular doxorubicin delivery. J Mater Chem. 2011;21:16420–16426. 10.1039/c1jm13357h
   Web of Science ®Google Scholar
• Wu H, Liu G, Zhang S, et al. Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands. J Mater Chem. 2011;21:3037–3045. 10.1039/c0jm02863k
   Web of Science ®Google Scholar
• Chen Y, Chen H, Zeng D, et al. Core/Shell structured hollow mesoporous nanocapsules: A potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano. 2010;4:6001–6013.
   PubMed Web of Science ®Google Scholar
• Zhao W, Chen H, Li Y, et al. Uniform rattle-type hollow magnetic mesoporous spheres as drug delivery carriers and their sustained-release property. Adv Funct Mater. 2008;18:2780–2788. 10.1002/adfm.v18:18
   Web of Science ®Google Scholar
• Julian-Lopez B, Boissiere C, Chaneac C, et al. Mesoporous maghemite–organosilica microspheres: a promising route towards multifunctional platforms for smart diagnosis and therapy. J Mater Chem. 2007;17:1563–1569. 10.1039/B615951F
   Web of Science ®Google Scholar
• Ruiz-Hernandez E, Lopez-Noriega A, Arcos D, et al. Aerosol-assisted synthesis of magnetic mesoporous silica spheres for drug targeting. Chem Mater. 2007;19:3455–3463.
   Web of Science ®Google Scholar
• Martin-Saavedra FM, Ruiz-Hernandez E, Bore A, et al. Magnetic mesoporous silica spheres for hyperthermia therapy. Acta Biomater. 2010;6:4522–4531.
   PubMed Web of Science ®Google Scholar
• Lu F, Popa A, Zhou S, et al. Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia. Chem Commun. 2013;49:11436–11438.
   PubMed Web of Science ®Google Scholar
• Tao C, Zhu Y. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia. Dalton Trans. 2014;43:15482–15490.
   PubMed Web of Science ®Google Scholar
• Zhu Y and Tao C. DNA-capped Fe3O4/SiO2 magnetic mesoporous silica nanoparticles for potential controlled drug release and hyperthermia. RSC Adv. 2015;5:22365–22372. 10.1039/C5RA00701A
   Web of Science ®Google Scholar
• Liu J, Qiao SZ, Hartono SB, et al. Monodisperse yolk-shell nanoparticles with a hierarchical porous structure for delivery vehicles and nanoreactors. Angew Chem Int Ed. 2010;49:4981–4985. 10.1002/anie.v49:29
   PubMed Web of Science ®Google Scholar
• Souza KC, Mohallem NDS, Sousa EMB. Mesoporous silica-magnetite nanocomposite: facile synthesis route for application in hyperthermia. J Sol-Gel Sci Technol. 2010;53:418–427. 10.1007/s10971-009-2115-y
   Web of Science ®Google Scholar
• Wang H, Chen QW, Yu YF, et al. Size- and solvent-dependent magnetically responsive optical diffraction of carbon-encapsulated superparamagnetic colloidal photonic crystals. J Phys Chem C. 2011;115:11427–11434. 10.1021/jp201893z
   Web of Science ®Google Scholar
• Shen D, Yang J, Li X, et al. Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. Nano Lett. 2014;14:923–932.
   PubMed Web of Science ®Google Scholar